Tenecteplase Fails to Boost EVT Outcomes - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Tenecteplase Fails to Boost EVT Outcomes

Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.

  • By

  • Kathryn Wighton

  • May 14, 2026

  • 6 min

Share

Original Source(s)

Tenecteplase Fails to Boost EVT Outcomes

  • by Kathryn Wighton

  • May 14, 2026

Related Content

Commentary: Identifying key predictors of post-stroke depression and cognitive impairment in acute stroke survivors

CREST-2 Findings Highlight Evolving Role of Carotid Artery Stenting

New findings from CREST-2 are providing important evidence on the role of carotid artery stenting (CAS) in patients with severe asymptomatic carotid stenosis — while underscoring the importance of operator experience, patient selection and procedural technique in achieving favorable outcomes.

  • by

  • September 14, 2026

  • 5 min
Neuroprosthesis for paralysis enables simultaneous speech and body language

  • September 14, 2026